Literature DB >> 10340976

Decreased tear lactoferrin concentration in patients with chronic hepatitis C.

T Abe1, A Nakajima, M Matsunaga, S Sakuragi, M Komatsu.   

Abstract

BACKGROUND/AIMS: Decreased tear volume in patients with chronic hepatitis C has been reported in the literature. Lactoferrin is abundantly present in human tears, the main source of which is the acini of the lacrimal glands. In this study tear lactoferrin levels were measured to investigate the dry eye condition of patients with chronic hepatitis C.
METHODS: Lactoferrin in tears/fluid was measured by a radial immunodiffusion assay in 42 patients with chronic hepatitis C. The rate of lacrimal secretion was determined by the cotton thread test. Rose bengal staining of the ocular surface was also performed.
RESULTS: Only three patients out of 42 complained of dry eye sensation and, in 31 patients, six showed positive results on the rose bengal staining test of the ocular surface. The lactoferrin concentration of tear fluid in the chronic hepatitis C group (1.42 (SD 0.56) mg/ml) was significantly lower than in the control group (1.90 (0.62) mg/ml; p <0.00048). The cotton thread test results in the chronic hepatitis C group (12.9 (5. 5) mm) were significantly lower than in the control group (17.9 (5. 3) mm; p<0.00048). Also, in the chronic hepatitis C group, tear lactoferrin concentration correlated with the results of the cotton thread test (r = 0.35, p<0.05).
CONCLUSION: Chronic hepatitis C patients showed both decreased tear volume, and decreased tear lactoferrin concentration. These findings suggest that there may be dysfunction of the lacrimal glands in patients with chronic hepatitis C, which may account for the mild dry eye.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10340976      PMCID: PMC1723068          DOI: 10.1136/bjo.83.6.684

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  22 in total

1.  Lichen planus, liver kidney microsomal (LKM1) antibodies and hepatitis C virus antibodies.

Authors:  M C Divano; A Parodi; A Rebora
Journal:  Dermatology       Date:  1992       Impact factor: 5.366

2.  Changes in human tear protein levels with progressively increasing stimulus.

Authors:  R J Fullard; D L Tucker
Journal:  Invest Ophthalmol Vis Sci       Date:  1991-07       Impact factor: 4.799

3.  Hepatitis C virus RNA in saliva.

Authors:  K Takamatsu; Y Koyanagi; K Okita; N Yamamoto
Journal:  Lancet       Date:  1990-12-15       Impact factor: 79.321

4.  Tear fluid proteins in Sjögren's syndrome.

Authors:  P T Janssen; O P van Bijsterveld
Journal:  Scand J Rheumatol Suppl       Date:  1986

5.  Diagnostic tests in the Sicca syndrome.

Authors:  O P van Bijsterveld
Journal:  Arch Ophthalmol       Date:  1969-07

6.  Development of Sjögren's syndrome during treatment with recombinant human interferon-alpha-2b for chronic hepatitis C.

Authors:  H Unoki; A Moriyama; A Tabaru; A Masumoto; M Otsuki
Journal:  J Gastroenterol       Date:  1996-10       Impact factor: 7.527

7.  A simple test for lacrimal gland function: a tear lactoferrin assay by radial immunodiffusion.

Authors:  P T Janssen; O P van Bijsterveld
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1983       Impact factor: 3.117

8.  A new method for measuring tears.

Authors:  H Hamano; M Hori; T Hamano; S Mitsunaga; J Maeshima; S Kojima; H Kawabe; T Hamano
Journal:  CLAO J       Date:  1983 Jul-Sep

9.  Lymphocytic sialadenitis of Sjögren's syndrome associated with chronic hepatitis C virus liver disease.

Authors:  J Haddad; P Deny; C Munz-Gotheil; J C Ambrosini; J C Trinchet; D Pateron; F Mal; P Callard; M Beaugrand
Journal:  Lancet       Date:  1992-02-08       Impact factor: 79.321

10.  Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources.

Authors:  H Okamoto; Y Sugiyama; S Okada; K Kurai; Y Akahane; Y Sugai; T Tanaka; K Sato; F Tsuda; Y Miyakawa
Journal:  J Gen Virol       Date:  1992-03       Impact factor: 3.891

View more
  6 in total

Review 1.  Ocular side effects of anti-rheumatic medications: what a rheumatologist should know.

Authors:  V Peponis; V C Kyttaris; S E Chalkiadakis; S Bonovas; N M Sitaras
Journal:  Lupus       Date:  2010-02-09       Impact factor: 2.911

2.  Histopathological Studies on Rabbits Infected by Bacteria Causing Infectious Keratitis in Human through Eye Inoculation.

Authors:  Yousef H Aldebasi; Hala A Mohamed; Salah M Aly
Journal:  Int J Health Sci (Qassim)       Date:  2014-07

3.  Mucin inhibits Pseudomonas aeruginosa biofilm formation by significantly enhancing twitching motility.

Authors:  Cecily L Haley; Cassandra Kruczek; Uzma Qaisar; Jane A Colmer-Hamood; Abdul N Hamood
Journal:  Can J Microbiol       Date:  2014-01-24       Impact factor: 2.419

4.  Ophthalmological implications of the chronic infections with the hepatitis C Virus.

Authors:  Alexa Anisia-Iuliana; Cantermir Alina; Ciuntu Roxana Elena; Chiseliţă Dorin
Journal:  Rom J Ophthalmol       Date:  2015 Oct-Dec

5.  Lactoferrin Concentration in Human Tears and Ocular Diseases: A Meta-Analysis.

Authors:  Erika Ponzini; Lorenza Scotti; Rita Grandori; Silvia Tavazzi; Antonella Zambon
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-10-01       Impact factor: 4.799

Review 6.  Practical issues concerning tear protein assays in dry eye.

Authors:  Sharon D'Souza; Louis Tong
Journal:  Eye Vis (Lond)       Date:  2014-11-13
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.